Package Leaflet: Information for the User
Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.
Contents of the package leaflet
Tadalafil Zentiva contains the active substance tadalafil, which belongs to a group of medicines called phosphodiesterase type 5 inhibitors.
Tadalafil Zentiva 5 mg is used for the treatment of adult men with:
Consult your doctor or pharmacist before starting to take this medicine.
Be aware that sexual activity carries a possible risk to patients with heart problems, due to the extra strain it puts on the heart. If you have a heart problem, consult your doctor.
As benign prostatic hyperplasia and prostate cancer can have the same symptoms, your doctor will check you for prostate cancer before starting treatment with tadalafil for benign prostatic hyperplasia. Tadalafil does not treat prostate cancer.
Before taking the tablets, tell your doctor if you have:
It is not known if tadalafil is effective in patients who have been treated with:
If you experience sudden loss of vision or your vision is distorted, blurred, or diminished while taking tadalafil, stop taking tadalafil and contact your doctor immediately.
Sudden loss of hearing has been observed in some patients taking tadalafil. Although it is not known if the event is directly related to tadalafil, if you experience sudden loss of hearing, stop taking this medicine and contact your doctor immediately.
Tadalafil is not intended for use in women.
Tadalafil should not be used in children and adolescents under 18 years of age.
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines.
Do not take tadalafil if you are already using nitrates.
Some medicines may be affected by tadalafil or may affect the way tadalafil works. Tell your doctor or pharmacist if you are using:
Information about the effect of alcohol is in section 3. Grapefruit juice may affect the way tadalafil works and should be taken with caution. Consult your doctor for more information.
In dogs treated with tadalafil, a decrease in sperm production by the testicles was observed. A reduction in sperm has been observed in some men. It is unlikely that these effects will produce a lack of fertility.
Some men who took tadalafil during clinical trials experienced dizziness. Check carefully how you react when taking the tablets before driving or using machines.
This medicine contains lactose. If your doctor has told you that you have an intolerance to some sugars, consult your doctor before taking this medicine.
This medicine contains less than 1 mmol of sodium (23 mg) per tablet; this is essentially "sodium-free".
Follow exactly the administration instructions of this medicine given by your doctor. In case of doubt, consult your doctor or pharmacist again.
The tablets of this medicine are for oral administration only in men. Swallow the tablet whole with a little water. The tablets can be taken with or without food.
Consuming alcohol may temporarily lower your blood pressure. If you have taken or plan to take tadalafil, avoid excessive alcohol consumption (blood alcohol level of 0.08% or higher), as it may increase the risk of dizziness when standing up.
For the treatment of erectile dysfunction
The recommended doseis one 5 mg tablet once a day, approximately at the same time. Your doctor may adjust the dose to 2.5 mg based on your response to tadalafil. This will be done by taking a 2.5 mg tablet. As Tadalafil Zentiva is not available in 2.5 mg film-coated tablets, the availability of other suitable formulations should be checked.
Do not take tadalafil more than once a day.
Tadalafil taken daily allows you to get an erection at any time during the 24 hours of the day, provided that there is sexual stimulation. Tadalafil taken daily may be useful in men who anticipate having sexual activity twice or more per week.
It is important to note that tadalafil is not effective if there is no sexual stimulation. You and your partner should stimulate yourselves in the same way as you would if you were not taking a medicine for erectile dysfunction.
Consuming alcohol may affect your ability to get an erection.
For the treatment of benign prostatic hyperplasia
The dose is one 5 mg tablet once a day, approximately at the same time. If you have benign prostatic hyperplasia and erectile dysfunction, the dose remains one 5 mg tablet once a day.
Do not take tadalafil more than once a day.
If you take more Tadalafil Zentiva than you should
Consult your doctor. You may experience side effects described in section 4.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately, or call the Toxicological Information Service, phone: 91 562 04 20, indicating the medicine and the amount taken. It is recommended to take the package and the package leaflet of the medicine to the healthcare professional.
If you forget to take Tadalafil Zentiva
Take your dose as soon as you remember. Do not take a double dose to make up for forgotten doses. Do not take tadalafil more than once a day.
If you have any further questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them. These effects are usually mild to moderate.
If you experience any of the following side effects, stop using the medicine and seek medical help immediately:
Other side effects that have been reported:
Common (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1,000 people)
Heart attack and stroke have also been reported rarely in men taking tadalafil. Most of these men had pre-existing heart problems.
Sudden loss of vision, partial, transient, or permanent in one or both eyes has been reported rarely.
Some additional rare side effects have been reportedin men taking tadalafil that were not reported during clinical trials. These include:
In men over 75 years of age treated with tadalafil, the most frequently reported side effect was dizziness. In men over 65 years of age treated with tadalafil, the most frequently reported side effect was diarrhea.
If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this package leaflet. You can also report side effects directly to the Spanish Medicines and Healthcare Products Agency (AEMPS) through the website: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging after "EXP". The expiry date is the last day of the month stated.
This medicine does not require any special storage conditions.
Medicines should not be disposed of via wastewater or household waste. Return any unused medicine to your pharmacist. This will help protect the environment.
Composition of Tadalafil Zentiva
Core of the tablet: lactose monohydrate, pregelatinized starch, colloidal anhydrous silica, sodium croscarmellose, sodium lauryl sulfate, magnesium stearate.
Coating: hypromellose, lactose monohydrate, titanium dioxide (E171), triacetin, talc (E553b), yellow iron oxide (E172), red iron oxide (E172).
Appearance and packaging of the product
Tadalafil Zentiva 5 mg is a film-coated tablet (tablet), oval in shape, pale yellow in color, engraved with a "5" on one side and smooth on the other. The tablet is 10 mm x 6.0 mm in diameter and 3.3 - 3.9 mm in thickness.
Pack sizes
Tadalafil Zentiva 5 mg is available in blisters containing 14, 28, and 84 tablets.
Not all pack sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder
Zentiva k.s.
U kabelovny 130
Dolní Mecholupy
102 37 Prague 10
Czech Republic
Manufacturer
Actavis Ltd
BLB016, Bulebel Industrial Estate
Zejtun ZTN 3000
Malta
Balkanpharma Dupnitsa AD
3 Samokovsko Shosse Street
Dupnitsa, 2600
Bulgaria
Special Products's Line S.P.A.
Via Fratta Rotonda Vado Largo 1
03012 Anagni (FR)
Italy
You can obtain further information on this medicine by contacting the local representative of the marketing authorization holder:
Zentiva Spain S.L.U.
Avenida de Europa, 19, Edificio 3, Planta 1.
28224 Pozuelo de Alarcón, Madrid
Spain
This medicine is authorized in the Member States of the European Economic Area under the following names:
Germany | Tadalafil Zentiva 5 mg film-coated tablets |
Spain | Tadalafil Zentiva 5 mg film-coated tablets EFG |
Estonia | Tadalafil Zentiva |
Italy | Tadalafil Zentiva, 5 mg film-coated tablet |
Latvia | Tadalafil Zentiva 20 mg film-coated tablets |
Lithuania | Tadalafil Zentiva 5 mg film-coated tablets |
Portugal | Tadalafil Zentiva |
Czech Republic | Tadalafil Zentiva |
Sweden | Tadalafil Zentiva 5 mg film-coated tablets |
Date of last revision of this package leaflet: January 2024
Other sources of information:
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) http://www.aemps.gob.es/